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the natural history of human tumors. First 
of all, the Cyclin D1 and Cdk4 mutations 
used in these studies were introduced 
in the germline, not in advanced tumors 
(RNAi results must be interpreted more 
cautiously, since other loci may be affect-
ed). More importantly, the etiology of 
experimental tumors differs significantly 
from that of human cancers. For instance, 
experimental mouse tumors often arise 
from tissues in which most cells carry the 
tumor-inducing mutation (MMTV-driven 
c-neu/erbB-2 expression in the papers 
discussed here). In contrast, human 
tumors, especially solid tumors, result 
from mutations in single or few cells that 
accumulate additional mutations through 
a process of clonal selection. Thus, tumor 
development in human patients is likely to 
be less dependent on any given mutated 
gene than experimental tumors. Yet, these 
considerations should not be an excuse to 
further delay testing in patients suffering 
from HER-2-positive breast tumors the 
effectiveness of selective Cdk4/6 inhibi-
tors, as suggested by these new studies 
(Landis et al., 2006; Yu et al., 2006).
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The non-receptor tyrosine kinase Src is inactivated by the C-terminal Src kinase Csk. In a recent paper in Developmental Cell, 
Vidal et al. show that loss of Drosophila Csk (dCsk) in a large field of cells results in cell proliferation and disorganization of 
tissue architecture. In contrast, local inactivation of dCsk in a small field of cells results in loss of cells that are adjacent to 
normal tissue. This loss occurs by basal migration and death by apoptosis. These findings may shed light on mechanisms 
that restrain tumor initiation.During the progression of many epithelial 
cancers, including breast and colon carci-
nomas, the expression and activity of the 
tyrosine kinase Src becomes progres-
sively elevated. Src activity appears to be 
particularly important in tumor cell inva-
sion and metastasis (Frame, 2002). Thus, 
inhibition of Src inhibits tumor metastasis 
in a number of xenograft models, as well 
as in transgenic mice overexpressing 
polyoma middle T or Her2. In cell culture, 
activated Src induces the appearance of 
invasive adhesions known as podosomes 
or invadopodia, sites of local matrix degra-
dation. The pathway by which Src induces 
cell invasion through reconstituted base-
ment membrane matrices involves the 
activation of the focal adhesion kinase 
(FAK) and the stress-activated Jun kinase 
	(JNK), and the induction and local secre-
tion of matrix metalloproteinases and 
other matrix-degrading proteases (Hsia 
et al., 2003). Activated Src is capable 
of inducing autonomous cell prolifera-
tion and cell transformation: viral src is a 
potent transforming gene. Yet mutations 
that activate Src are found rarely if at all 
in human cancers, and those that have 
been reported—the report has been dis-
puted—occur in advanced metastatic can-
cers (Irby et al., 1999). The reason that 
activating mutations in Src do not appear 
to initiate human cancers is unknown.
One potential explanation for the rarity 
of activating mutations in Src is the abil-
ity of normal cells to suppress the malig-
nant behavior of mutant cells within their 
midst. In cell culture, normal fibroblasts can suppress the transformed phenotype 
of Src-transformed fibroblasts, a phenom-
enon that does not appear to depend on 
junctional communication (Alexander 
et al., 2004). Similar tumor-suppressive 
mechanisms may operate in vivo. For 
example, normal liver tissue can induce 
the differentiation of injected hepatocarci-
noma cells, provided that the tumor cells 
are present in small groups or single cells 
(McCullough et al., 1998). Similarly, the 
formation of tumors by grafted papilloma 
cells can be suppressed by admixture with 
normal keratinocytes (Strickland et al., 
1992). Inhibition of tumor cell growth by 
adjacent normal cells has been postulated 
to represent a potent tumor suppression 
mechanism.
New light on these issues may now cancer cell January	2006	
	 p r e v i e w shave been shed by a recent study of Cagan 
and coworkers (Vidal et al., 2006). They 
used that well-known tumor model, the 
fruit fly Drosophila, to examine the results 
of Src activation in groups of adjacent 
cells. Local activation was achieved by the 
regulated expression of an RNAi construct 
that inhibited expression of the Drosophila 
homolog of Csk, dCsk. dCsk inhibits the 
activity of the Src isoform dSrc64B, and 
previous work from this group had shown 
that the effects of loss of dCsk are medi-
ated by Src activation (Read et al., 2004). 
When dCsk expression was blocked in a 
large field of cells in the fly eye or wing, 
the entire structure became enlarged 
and disorganized. In the retina, the loss 
of dCsk led to an increase in cell number, 
as a result of both increased proliferation 
and decreased apoptosis. Furthermore, 
loss of dCsk and the consequent acti-
vation of dSrc suppressed apoptosis 
induced by expression of the apoptosis 
inducers Reaper and Hid. Mammalian 
Src is involved in mitogenic signaling by 
integrins and growth factor receptors, and 
it is well known that Src, although proa-
poptotic under some circumstances, can 
suppress apoptosis by inducing Ras-MAP 
kinase, PI-3-kinase-Akt, and Stat3 signal-
ing. Thus, the mitogenic and antiapoptotic 
effects of Drosophila Src (presumably 
dSrc64B) came as no surprise.
In addition to its effect on cell prolifera-
tion and cell death, Src activation resulted 
in disruption of tissue architecture. In the 
normal eye, interommatidial precursor 
cells differentiate into pigment cells and 
sensory bristles that form an organized 
hexagonal lattice surrounding the indi-
vidual facets or ommatidia. On suppres-
sion of Csk expression, the patterning of 
these cells became disorganized. Time-
lapse movies revealed that this patterning 
defect was due not to a failure of cells to 
undergo the required movements, but to 
a failure to maintain correct positioning, 
possibly as result of a failure in cell adhe-
sion. Both mammalian and Drosophila 
Src are known to decrease E-cadherin-
dependent adhesion. Consistent with the 
idea that the patterning defect was due to 
inhibition of E-cadherin-mediated adhe-
sion, the level of Armadillo (β-catenin) 
was decreased in dCsk-deficient cells, 
and the patterning defects due to dCsk 
deficiency (but not the tissue overgrowth) 
could be suppressed by coexpression of 
Drosophila E-cadherin. Again, the effects 
of Src activation in Drosophila seemed 
very consistent with its effects in mam-cancer cell January	2006		malian cell culture systems.
The surprise came when discrete 
patches of dCsk-deficient cells surround-
ed by normal cells were generated. This 
was achieved by expressing the dCsk 
RNAi construct in clonal patches or with 
a promoter with a restricted expression 
domain. Unlike patches of cells generat-
ed by inactivation of many other fly tumor 
suppressors, these patches of dCsk-defi-
cient cells did not overgrow the adjacent 
normal tissue. Instead, cells with activated 
Src at the patch boundary were basally 
extruded from the epithelium and under-
went apoptotic cell death. Whether any of 
these cells were actually migrating into 
or across the basement membrane was 
not established in this study, and it would 
presumably require electron microscopy 
to resolve this question. Nevertheless, it is 
intriguing to note that the basal migration 
of the cells could be inhibited by reducing 
the expression of the Drosophila matrix 
metalloproteinase MMP2 or by coexpres-
sion of the tissue inhibitor of metallopro-
teinases (TIMP). Thus, like the invasive 
migration of mammalian Src-transformed 
cells through reconstituted basement 
membrane matrix, the basal migration 
of dCsk-deficient cells appeared to be 
dependent on matrix metalloproteinase 
function. Strikingly, therefore, when dCsk-
deficient cells are adjacent to normal cells, 
the same functions that in mammalian 
cells are responsible for Src-induced cell 
invasion induce the basal migration of the 
cells and their death by apoptosis.
To explore the signaling pathways by 
which migration and apoptosis of Csk-
deficient cells is induced when the cells 
are adjacent to normal cells, Vidal et al. 
examined the effects of inhibiting media-
tors of apoptotic signaling, cell migration, 
and E-cadherin-dependent adhesion. The 
Drosophila JNK ortholog dJNK has been 
implicated in the apoptotic elimination of 
clonal patches of cells that are mutant for 
the tumor suppressor scribble (Brumby 
and Richardson, 2003). Inhibiting dJNK 
activation (by overexpression of the 
dJnk-specific phosphatase Puckered or 
by coexpression of a dominant-negative 
dJnk) blocked the migration of dCsk-defi-
cient cells, while promoting dJnk activa-
tion (by reducing the dose of Puckered) 
promoted migration and cell death. 
Overexpression of the Drosophila Rho 
protein Rho1 promoted cell migration and 
death, whereas a reduction in the dose of 
Rho1 decreased the migration and apop-
tosis of dCsk-deficient cells. Rho1 has also been shown to be required for the basal 
migration of Drosophila imaginal disc cells 
lacking Moesin, which display a pheno-
type similar to those of dCsk cells (Speck 
et al., 2003). The involvement of Rho1 is 
of particular interest, because it has been 
shown that the assembly and function 
of Src-induced podosomes in mamma-
lian cells is dependent on Rho function 
(Berdeaux et al., 2004). Furthermore, in 
colon cancer cells Src-induced deregu-
lation of E-cadherin is dependent on the 
Rho-regulated kinase ROCK (Avizienyte 
et al., 2004). The migration and apoptosis 
of dCsk cells from discrete patches was 
suppressed by reducing the dose of dE-
cadherin, seemingly pointing to a positive 
role for dE-cadherin in basal migration and 
cell death. Finally, flies contain a homolog 
of the mammalian Src substrate p120-cat-
enin, a component of E-cadherin-contain-
ing adherens junctions. A reduction in the 
expression of this protein, dP120ctn, also 
reduced the migration and apoptosis of 
dCsk cells. Thus, it appears that dJnk, 
Rho1, dE-cadherin, and dP120ctn all act 
positively in the pathways that induce cell 
migration and apoptosis.
What mechanisms can account for 
the selective migration and death of dCsk-
deficient cells that are adjacent to normal 
tissue? It seems there are significant dif-
ferences in the signaling pathways that 
induce proliferation and tissue disruption 
in broad fields of dCsk cells and those that 
induce migration and apoptosis in discrete 
patches. For example, although the dis-
turbances in patterning resulting from 
inactivation of dCsk in a large field were 
suppressed by overexpression of dE-cad-
herin, the migration and apoptosis of dCsk 
cells from smaller fields were in contrast 
suppressed by reducing the dose of dE-
cadherin. Reducing the dose of Rho1 or 
dP120ctn inhibited the basal migration of 
dCsk-deficient cells in discrete patches 
but had no effect on the phenotype of 
dCsk cells in large fields. On the basis of 
these observations, Vidal et al. propose 
a model in which the homotypic interac-
tions between E-cadherin molecules on 
adjacent cells produce different signal-
ing outcomes when both adjacent cells 
are dCsk-deficient and when one cell is 
dCsk-deficient while its adjacent neighbor 
is normal.
But perhaps modified versions of this 
model should also be considered. For 
example, another view is that the basal 
extrusion observed in dCsk patches might 
be a secondary consequence of the proc-
	 p r e v i e w sess of apoptosis. If, for example, the dCsk 
cells in these patches proliferate more 
slowly than their neighbors, they might 
be eliminated by competition. This is the 
process by which rapidly growing cells 
eliminate more slowly growing neighbors 
by JNK-dependent apoptosis (Gallant, 
2005); in this process the apoptotic cells 
are also basally extruded. It would thus 
be interesting to determine whether basal 
migration still occurs when apoptosis is 
suppressed. An alternative possibility 
is that the apoptosis is a consequence 
of basal migration. Epithelial cells are 
dependent on cell-cell and cell-matrix sig-
nals for their survival. Cells that migrate 
basally from their normal position might 
therefore undergo apoptosis because 
they are deprived of antiapoptotic signals 
present in their normal niche. Thus, on 
this view the death of the migratory cells 
might be secondary to their movement 
out of a protective niche within the intact 
epithelium. The finding that loss of MMP2 
blocks both basal migration and cell death 
is consistent with this latter view.
Irrespective of the precise model 
invoked to explain these observations, 
it seems clear that tissue context can 
determine the outcome of Src activation. 
Some of the same signaling pathways and 6	
Colorectal cancer is a global concern that 
accounts for over 50,000 cancer-related 
deaths each year in the United States alone 
(Jemal et al., 2005). Colorectal cancer 
develops following mutations of key onco-
genes such as Ras or disruption of tumor 
suppressor genes such as APC (adeno-
matous polyposis coli) and p53. The loss of 
function of DNA repair genes coupled with 
genomic instability also leads to the devel-
opment of colorectal cancer. Hereditary 
predisposition for colorectal polyps and 
cancer occurs in people with familial ade-
nomatous polyposis (FAP). These patients 
Connecting COX-2 and
Both the cyclooxygenase-2 (COX-2) and W
a direct link between these two key pathw
of COX-2, prostaglandin E2, activates comp
important crosstalk between these pathw
ment and/or prevention of colorectal cancmolecules that act to promote mammalian 
tumor development and metastasis can, 
at least in the fly, function to promote cell 
death when activated in small groups of 
cells. Clearly the question now is: does 
discrete activation of Src have similar 
effects in mammalian epithelia, and does 
this account for the failure of mutationally 
activated Src to initiate tumor formation 
in man? Introduction of a conditionally 
expressed allele of activated Src into 
the mouse genome might provide the 
answer.
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develop in these mice.
Although there is a temporal asso-
ciation between the loss of APC function 
and the activity of COX-2 in vivo, there 
has been little evidence showing a direct 
connection between these pathways 
(Shao et al., 2005; Fujino et al., 2002). In 
a recent report, Castellone et al. identi-
fied a direct link between COX-2 and Wnt 
and have begun to dissect precisely how 
these signaling cascades are intertwined 
(Castellone et al., 2005). Using colorectal 
carcinoma cells in vitro, they show that 
prostaglandin E2 (PGE2) increased the 
ority of colorectal cancers. Nevertheless, 
 show that one of the bioactive products 
tem. The findings reviewed below reveal 
 the development of new drugs for treat-
